Metabolic dysfunction associated fatty liver disease identifies subjects with cardiovascular risk better than nonalcoholic fatty liver disease

HEPATOLOGY(2023)

引用 3|浏览38
暂无评分
摘要
MAFLD might better identify subjects with CVD risk than NAFLD. Fibrosis assessment might be helpful for detailed prognostication in subjects with MAFLD.
更多
查看译文
关键词
cardiovascular disease,liver fibrosis,metabolic dysfunction-associated fatty liver disease,non-alcoholic fatty liver disease
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要